Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.

Abstract:

:Novel synthetic antagonists of retinoic acid receptors (RARs) have been developed. To avoid interference by serum retinoids when testing these compounds, we established serum-free grown sub-lines (>3 years) of the prostate carcinoma lines LNCaP, PC3 and DU145. A high affinity pan-RAR antagonist (AGN194310, K(d) for binding to RARs = 2-5 nM) inhibited colony formation (by 50%) by all three lines at 16-34 nM, and led to a transient accumulation of flask-cultured cells in G1 followed by apoptosis. AGN194310 is 12-22 fold more potent than all-trans retinoic acid (ATRA) against cell lines and also more potent in inhibiting the growth of primary prostate carcinoma cells. PC3 and DU145 cells do not express RARbeta, and an antagonist with predominant activity at RARbeta and RARgamma (AGN194431) inhibited colony formation at concentrations (approximately 100 nM) commensurate with a K(d)value of 70 nM at RARgamma. An RARalpha antagonist (AGN194301) was less potent (IC(50) approximately 200 nM), but was more active than specific agonists of RARalpha and of betagamma. A component(s) of serum and of LNCaP-conditioned medium diminishes the activity of antagonists: this factor is not the most likely candidates IGF-1 and EGF. In vitro studies of RAR antagonists together with data from RAR-null mice lead to the hypothesis that RARgamma-regulated gene transcription is necessary for the survival and maintenance of prostate epithelium. The increased potencies of RAR antagonists, as compared with agonists, suggest that antagonists may be useful in the treatment of prostate carcinoma.

journal_name

Br J Cancer

authors

Hammond LA,Van Krinks CH,Durham J,Tomkins SE,Burnett RD,Jones EL,Chandraratna RA,Brown G

doi

10.1054/bjoc.2001.1939

subject

Has Abstract

pub_date

2001-08-03 00:00:00

pages

453-62

issue

3

eissn

0007-0920

issn

1532-1827

pii

S0007092001919391

journal_volume

85

pub_type

杂志文章
  • The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis.

    abstract:BACKGROUND:Body mass index (BMI) has been associated with the risk of oesophageal cancer. But the influence of BMI on postoperative complication and prognosis has always been controversial. METHODS:In total, 2031 consecutive patients who underwent oesophagectomy between 1998 and 2008 were classified according to Asian...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1038/bjc.2013.666

    authors: Zhang SS,Yang H,Luo KJ,Huang QY,Chen JY,Yang F,Cai XL,Xie X,Liu QW,Bella AE,Hu RG,Wen J,Hu Y,Fu JH

    更新日期:2013-11-26 00:00:00

  • Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.

    abstract::In the UK, 10% of patients diagnosed with rectal cancer have inoperable disease at presentation. This study ascertained whether the resectability rate of inoperable locally advanced rectal cancer was improved by administration of intravenous irinotecan, 5-fluorouracil (5-FU) and pelvic radiotherapy. During phase I of ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604292

    authors: Iles S,Gollins S,Susnerwala S,Haylock B,Myint S,Biswas A,Swindell R,Levine E

    更新日期:2008-04-08 00:00:00

  • Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type.

    abstract:BACKGROUND:Although salt intake is considered a probable risk factor for gastric cancer, relevant studies have provided heterogeneous results, and the magnitude of the association has not been accurately quantified. METHODS:To quantify gastric cancer risk in relation to dietary salt exposure according to Helicobacter ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605993

    authors: Peleteiro B,Lopes C,Figueiredo C,Lunet N

    更新日期:2011-01-04 00:00:00

  • Protein expression profiles indicative for drug resistance of non-small cell lung cancer.

    abstract::Data obtained from multiple sources indicate that no single mechanism can explain the resistance to chemotherapy exhibited by non-small cell lung carcinomas. The multi-factorial nature of drug resistance implies that the analysis of comprising expression profiles may predict drug resistance with higher accuracy than s...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600463

    authors: Volm M,Koomägi R,Mattern J,Efferth T

    更新日期:2002-07-29 00:00:00

  • The impact of genetic counselling on risk perception in women with a family history of breast cancer.

    abstract::Women with a family history of breast cancer generally self-refer because they have a feeling that their risk is high. However, they have, in general, only a hazy notion of the population risk of breast cancer and their own risk in relation to this. It is probable that they are helped by genetic counselling and, if at...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1994.423

    authors: Evans DG,Blair V,Greenhalgh R,Hopwood P,Howell A

    更新日期:1994-11-01 00:00:00

  • Rural and urban differences in stage at diagnosis of colorectal and lung cancers.

    abstract::There is evidence that patients living in outlying areas have poorer survival from cancer. This study set out to investigate whether they have more advanced disease at diagnosis. Case notes of 1323 patients in north and northeast Scotland who were diagnosed with lung or colorectal cancer in 1995 or 1996 were reviewed....

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2000.1708

    authors: Campbell NC,Elliott AM,Sharp L,Ritchie LD,Cassidy J,Little J

    更新日期:2001-04-06 00:00:00

  • Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.

    abstract::Insulin-like growth factors (IGFs) I and II are implicated in progression of various tumours including colorectal carcinomas. To interfere with the production of IGFs, we treated male nude mice bearing xenografts of HT-29 human colon cancer with various potent growth hormone-releasing hormone (GH-RH) antagonists. Twic...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2000.1223

    authors: Szepeshazi K,Schally AV,Groot K,Armatis P,Halmos G,Herbert F,Szende B,Varga JL,Zarandi M

    更新日期:2000-05-01 00:00:00

  • Telomerase activity in benign and malignant human thyroid tissues.

    abstract::Telomerase is a specialized ribonucleoprotein polymerase that directs the synthesis of telomerase repeats at chromosome ends. Accumulating evidence has indicated that telomerase is stringently repressed in normal human somatic tissues but reactivated in cancers and immortal cells, suggesting that activation of telomer...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1998.363

    authors: Cheng AJ,Lin JD,Chang T,Wang TC

    更新日期:1998-06-01 00:00:00

  • Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

    abstract::Serum levels of pepsinogen and gastrin are parameters that can be used as biomarkers for gastric mucosa. The aim of this study was to validate these serum biomarkers, that is pepsinogen A (PGA), pepsinogen C (PGC), PGA/PGC ratio, and gastrin, as screening tests for precancerous lesions: atrophic chronic gastritis (ACG...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600877

    authors: Broutet N,Plebani M,Sakarovitch C,Sipponen P,Mégraud F,Eurohepygast Study Group.

    更新日期:2003-04-22 00:00:00

  • Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.

    abstract::This randomised trial compared platinum-based to anthracycline-based chemotherapy in patients with small-cell lung cancer (limited or extensive stage) and

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/sj.bjc.6604480

    authors: Baka S,Califano R,Ferraldeschi R,Aschroft L,Thatcher N,Taylor P,Faivre-Finn C,Blackhall F,Lorigan P

    更新日期:2008-08-05 00:00:00

  • ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial.

    abstract:BACKGROUND:Cisplatin-radiotherapy is a preferred standard for locally advanced, head and neck squamous cell carcinoma (HNSCC). However, the cisplatin-attributable survival benefit is small and toxicity substantial. A biomarker of cisplatin resistance could guide treatment selection and spare morbidity. The ERCC1-XPF nu...

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/bjc.2013.576

    authors: Bauman JE,Austin MC,Schmidt R,Kurland BF,Vaezi A,Hayes DN,Mendez E,Parvathaneni U,Chai X,Sampath S,Martins RG

    更新日期:2013-10-15 00:00:00

  • Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.

    abstract::Germline anomalies of the INK4a-ARF and Cdk4 genes were sought in a series of 89 patients suspected of having a genetic predisposition to melanoma. Patients were selected based on the following criteria: (a) familial melanoma (23 cases), (b) multiple primary melanoma (MPM; 18 cases), (c) melanoma and additional unrela...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601503

    authors: Soufir N,Lacapere JJ,Bertrand G,Matichard E,Meziani R,Mirebeau D,Descamps V,Gérard B,Archimbaud A,Ollivaud L,Bouscarat F,Baccard M,Lanternier G,Saïag P,Lebbé C,Basset-Seguin N,Crickx B,Cave H,Grandchamp B

    更新日期:2004-01-26 00:00:00

  • A simple practical patient-reported clinic satisfaction measure for young adults.

    abstract:BACKGROUND:The development of practical patient-reported outcome measures (PROM) to assess the user view of health programmes is increasingly important. Valid, shorter instruments are more likely to be used and completed than extensive questionnaires. METHODS:Consecutive adult outpatient attendees who were long-term s...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605923

    authors: Phillips R,Absolom K,Stark D,Glaser A

    更新日期:2010-11-09 00:00:00

  • Endostatin expression in pancreatic tissue is modulated by elastase.

    abstract::Pancreatic tumours are scirrhous, avascular tumours, suggesting that they may produce angiogenesis inhibitors that suppress the growth of the vasculature to the tumour and metastases. We have sought evidence for the angiogenesis inhibitor, endostatin, in normal and cancerous pancreatic tissue. Using Western blotting, ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602234

    authors: Brammer RD,Bramhall SR,Eggo MC

    更新日期:2005-01-17 00:00:00

  • Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers.

    abstract:BACKGROUND:BRCAness is defined as shared tumour characteristics between sporadic and BRCA-mutated cancers. However, how to exactly measure BRCAness and its frequency in breast cancer is not known. Assays to establish BRCAness would be extremely valuable for the clinical management of these tumours. We assessed BRCAness...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.144

    authors: Lips EH,Mulder L,Oonk A,van der Kolk LE,Hogervorst FB,Imholz AL,Wesseling J,Rodenhuis S,Nederlof PM

    更新日期:2013-05-28 00:00:00

  • Lung tumour markers in oncology practice: a study of TPA and CA125.

    abstract::Several substances mark the course of lung cancer and may reliably help the clinician in decision-making. This is the first clinical study specifically designed to compare tissue polypeptide antigen and CA 125 tumour associated antigen. Three hundred and eighty-four new lung cancer patients (309 males) were studied at...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600577

    authors: Buccheri G,Ferrigno D

    更新日期:2002-11-04 00:00:00

  • Prevention of febrile neutropenia: use of prophylactic antibiotics.

    abstract::Febrile neutropenia (FN) causes significant morbidity and mortality in patients receiving cytotoxic chemotherapy and can lead to reduced chemotherapy dose intensity and increased overall treatment costs. Antibiotic prophylaxis reduces the incidence of FN. Recent research and meta-analyses confirm that prophylactic flu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605270

    authors: Cullen M,Baijal S

    更新日期:2009-09-01 00:00:00

  • Molecular alterations in a patient with Turcot's syndrome.

    abstract::Cells of a patient with Turcot's syndrome and of her parents were evaluated for the presence of molecular alterations in the p53 and the Ki-ras gene. Deletions on chromosome 17p, overexpression and point mutations of the p53 gene as well as mutations of the Ki-ras gene were detected in primary and metastatic tumour bu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1993.379

    authors: Rochlitz CF,Heide I,de Kant E,Neubauer A,Schmidt CA,Neuhaus P,Huhn D,Herrmann R

    更新日期:1993-09-01 00:00:00

  • Interaction of human serum albumin with anticancer agents in vitro.

    abstract::The influence of human serum albumin (HA) on the biological effects of 13 chemotherapeutic agents was studied in vitro in the human leukaemia cell line MOLT-3. On the basis of changes in biological activity influenced by HA, these drugs may be divided into three types. Type I agents include cis-diamminedichloroplatinu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.103

    authors: Takahashi I,Ohnuma T,Kavy S,Bhardwaj S,Holland JF

    更新日期:1980-04-01 00:00:00

  • The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro.

    abstract::The use of oncolytic viruses has received considerable attention in recent years and many viruses have proved to be effective against a variety of cancer models and a few are currently being used in clinical trials. However, the possible emergence and outcome of virus-resistant tumour cells has not been addressed. We ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6603363

    authors: Alain T,Kim M,Johnston RN,Urbanski S,Kossakowska AE,Forsyth PA,Lee PW

    更新日期:2006-10-23 00:00:00

  • Immunotherapy for acute myelogenous leukaemia.

    abstract::One hundred and seven untreated patients with acute myelogenous leukaemia (AML) were admitted to St Bartholomew's Hospital between 10 October 1970 and 31 January 1973. Before receiving drugs to induce remission they were allocated alternatively into 2 groups to decide their remission treatment-a group to receive chemo...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1038/bjc.1973.162

    authors: Powles RL,Crowther D,Bateman CJ,Beard ME,McElwain TJ,Russell J,Lister TA,Whitehouse JM,Wrigley PF,Pike M,Alexander P,Fairley GH

    更新日期:1973-11-01 00:00:00

  • Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.

    abstract::Oesophageal adenocarcinoma is believed to arise from metaplastic mucosa in the distal oesophagus, a condition also known as Barrett's oesophagus (BE). BE develops as a result of injury caused by refluxing gastric and duodenal contents and is associated with increased risk of malignant transformation. Matrix metallopro...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2001.1929

    authors: Salmela MT,Karjalainen-Lindsberg ML,Puolakkainen P,Saarialho-Kere U

    更新日期:2001-08-03 00:00:00

  • A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies.

    abstract::BGC9331 is a rationally designed, specific nonpolyglutamatable thymidylate synthase (TS) inhibitor that is active in gynaecological malignancies. In the light of the sensitivity of human ovarian tumour cell lines to BGC9331 and non-cross resistance to platinum drugs, we studied the combination BGC9331/carboplatin (BCA...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/sj.bjc.6602811

    authors: Benepal T,Jackman A,Pyle L,Bate S,Hardcastle A,Aherne W,Mitchell F,Simmons L,Ruddle R,Raynaud F,Gore M

    更新日期:2005-10-17 00:00:00

  • Treatment of upper aerodigestive tract cancers in England and its effect on survival.

    abstract::The evidence base for head and neck cancers is low with relatively few randomized controlled trials of the two main treatments, surgery and radiotherapy. The aim of the study was to investigate the patterns of surgery and radiotherapy treatment for head and neck cancers in three large areas of England and to investiga...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6690695

    authors: Edwards DM,Johnson NW

    更新日期:1999-09-01 00:00:00

  • A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.

    abstract:BACKGROUND:defective DNA repair has a causal role in hereditary colorectal cancer (CRC). Defects in the base excision repair gene MUTYH are responsible for MUTYH-associated polyposis and CRC predisposition as an autosomal recessive trait. Numerous reports have suggested MUTYH mono-allelic variants to be low penetrance ...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1038/sj.bjc.6605966

    authors: Theodoratou E,Campbell H,Tenesa A,Houlston R,Webb E,Lubbe S,Broderick P,Gallinger S,Croitoru EM,Jenkins MA,Win AK,Cleary SP,Koessler T,Pharoah PD,Küry S,Bézieau S,Buecher B,Ellis NA,Peterlongo P,Offit K,Aaltonen L

    更新日期:2010-12-07 00:00:00

  • Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?

    abstract::Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERbeta has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemic...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2001.1721

    authors: Skliris GP,Carder PJ,Lansdown MR,Speirs V

    更新日期:2001-04-20 00:00:00

  • Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.

    abstract:BACKGROUND:Faecal immunochemical tests (FITs) have replaced guaiac-based faecal occult blood test (gFOBTs) in several colorectal cancer (CRC) screening programmes. We aimed to evaluate the benefits of this transition based on the Wallonia-Brussels-organised CRC screening programme. METHODS:A total of 1,569,868 individ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-020-0754-5

    authors: Guo F,De Brabander I,Francart J,Candeur M,Polus M,Van Eycken L,Brenner H

    更新日期:2020-03-01 00:00:00

  • Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1.

    abstract:BACKGROUND:Impaired drug transport is an important factor that reduces the efficacy of anticancer agents against pancreatic cancer. Here, we report a novel combination chemotherapy using gemcitabine (GEM) and internalised-RGD (iRGD) peptide, which enhances tumour-specific drug penetration by binding neuropilin-1 (NRP1)...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2014.49

    authors: Akashi Y,Oda T,Ohara Y,Miyamoto R,Kurokawa T,Hashimoto S,Enomoto T,Yamada K,Satake M,Ohkohchi N

    更新日期:2014-03-18 00:00:00

  • Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

    abstract:BACKGROUND:Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majority of serous carcinom...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.34

    authors: Comamala M,Pinard M,Thériault C,Matte I,Albert A,Boivin M,Beaudin J,Piché A,Rancourt C

    更新日期:2011-03-15 00:00:00

  • Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats.

    abstract::In the present study the putative chemopreventive effect of dietary fish oil (MaxEPA) on azaserine-induced pancreatic carcinogenesis in rats was investigated. Groups of rats were maintained on a semipurified low-fat (LF; 5 wt%) diet or on semipurified high-fat (HF; 25 wt%) diets containing 5 wt% linoleic acid (LA) and...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.7

    authors: Appel MJ,Woutersen RA

    更新日期:1996-01-01 00:00:00